Free Trial

Biora Therapeutics (BIOR) SEC Filings & 10K Form

Biora Therapeutics logo
$0.13 0.00 (0.00%)
As of 02/19/2025

Recent Biora Therapeutics SEC Filings

DateFilerForm TypeView
12/30/2024
7:07 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:32 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:00 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
9:01 AM
Biora Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/29/2024
3:43 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:37 AM
Biora Therapeutics (Filer)
Form 424B5
10/29/2024
7:28 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:15 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:19 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:21 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:24 AM
Biora Therapeutics (Filer)
Form 424B3
10/23/2024
4:24 PM
Biora Therapeutics (Filer)
Form DEF 14A
10/11/2024
3:52 PM
Biora Therapeutics (Filer)
Form PRE 14A
10/11/2024
7:00 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:40 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/16/2024
3:30 PM
Biora Therapeutics (Filer)
Form DEF 14A
09/13/2024
9:37 AM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:02 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
09/03/2024
3:31 PM
Biora Therapeutics (Filer)
Form PRE 14A
08/23/2024
4:06 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:08 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:11 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:13 PM
Biora Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/23/2024
4:03 PM
Biora Therapeutics (Filer)
Form 424B5
08/21/2024
4:00 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:15 PM
Biora Therapeutics (Subject)
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
Form SC 13G
08/14/2024
8:57 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
8:58 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
08/12/2024
3:30 PM
Biora Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:15 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:05 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
8:42 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
07/08/2024
8:15 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
8:00 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:21 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
5:04 AM
Biora Therapeutics (Filer)
Form 424B5
07/01/2024
5:07 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:30 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:31 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Howe Jill Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
9/9 on TSLA from June to January (Ad)

Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!

Tap here to catch the TGT case study and learn more
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Alter Jeffrey D. (Reporting)
Biora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
04/24/2024
3:06 PM
Biora Therapeutics (Filer)
Form DEFA14A
04/24/2024
3:11 PM
Biora Therapeutics (Filer)
Form ARS
04/17/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
04/12/2024
3:30 PM
Biora Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:43 PM
Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
04/02/2024
3:44 PM
Biora Therapeutics (Filer)
Form 424B5
04/02/2024
3:46 PM
Biora Therapeutics (Filer)
Form 424B5
04/02/2024
3:48 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:45 PM
Biora Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:10 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
5:29 PM
Biora Therapeutics (Subject)
Context Capital Management, LLC (Filed by)
Form SCHEDULE 13G
03/11/2024
7:11 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIOR) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners